- Home
- AMRX vs XENE Comparison
AMRX vs XENE Comparison
Compare AMRX & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRX
- XENE
- Stock Information
- Founded
- AMRX 2002
- XENE 1996
- Country
- AMRX United States
- XENE Canada
- Employees
- AMRX N/A
- XENE N/A
- Industry
- AMRX Biotechnology: Pharmaceutical Preparations
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- AMRX Health Care
- XENE Health Care
- Exchange
- AMRX Nasdaq
- XENE Nasdaq
- Market Cap
- AMRX 3.3B
- XENE 2.9B
- IPO Year
- AMRX N/A
- XENE 2014
- Fundamental
- Price
- AMRX $10.21
- XENE $41.95
- Analyst Decision
- AMRX Buy
- XENE Strong Buy
- Analyst Count
- AMRX 3
- XENE 10
- Target Price
- AMRX $12.00
- XENE $53.00
- AVG Volume (30 Days)
- AMRX 1.4M
- XENE 742.2K
- Earning Date
- AMRX 10-30-2025
- XENE 11-03-2025
- Dividend Yield
- AMRX N/A
- XENE N/A
- EPS Growth
- AMRX N/A
- XENE N/A
- EPS
- AMRX 0.01
- XENE N/A
- Revenue
- AMRX $2,852,914,000.00
- XENE $7,500,000.00
- Revenue This Year
- AMRX $9.70
- XENE N/A
- Revenue Next Year
- AMRX $6.53
- XENE $207.88
- P/E Ratio
- AMRX $970.62
- XENE N/A
- Revenue Growth
- AMRX 9.81
- XENE N/A
- 52 Week Low
- AMRX $6.69
- XENE $26.74
- 52 Week High
- AMRX $10.68
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- AMRX 52.54
- XENE 57.52
- Support Level
- AMRX $10.13
- XENE $40.79
- Resistance Level
- AMRX $10.62
- XENE $42.77
- Average True Range (ATR)
- AMRX 0.28
- XENE 1.45
- MACD
- AMRX -0.01
- XENE -0.09
- Stochastic Oscillator
- AMRX 57.02
- XENE 53.41
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.